12:00 AM
Dec 17, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Oral finafloxacin: Phase II started

MerLion began a double-blind, double-dummy, European Phase II trial to compare 3.2 mg/mL IV finafloxacin and 200 mg oral finafloxacin for 5 or 10 days vs. oral and IV ciprofloxacin for 10 days in up to 258 patients. The oral formulation of finafloxacin has completed...

Read the full 202 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >